Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 3/2/22 → 1/24/26 |
Funding
- Eli Lilly and Company: $27,112.00
PIONEER-PEDS2-H8H-MC-LAHW(b): A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients with Migraine
- Qaiser, Sharoon (PI)